Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05776914
PHASE2

Fecal Microbiota Transplantation for IBS

Sponsor: Madhusudan (Madhu) Grover, MBBS

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.

Official title: Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)

Key Details

Gender

FEMALE

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

43

Start Date

2024-04-15

Completion Date

2026-12

Last Updated

2025-10-24

Healthy Volunteers

No

Interventions

BIOLOGICAL

Donor Fecal Microbiota Transplantation

Single fecal microbiota transplantation using 50 gm of freeze-thawed donor stool

BIOLOGICAL

Autologous Fecal Microbiota Transplantation

Single fecal microbiota transplantation using 50 gm of stool collected from the same individual

Locations (1)

Mayo Clinic in Minnesota

Rochester, Minnesota, United States